+258.4%
NVDA vs EMR
+103.5%
+154.9%
-36.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.9% | -0.3% | +3.2% | +3.0% |
| 7D | -13.2% | -2.0% | -11.2% | -12.1% |
| 30D | -23.2% | +2.8% | -26.1% | -24.5% |
| 3M | -20.0% | +2.0% | -22.0% | -21.1% |
| 6M | -20.6% | +20.7% | -41.4% | -29.7% |
| YTD | -6.6% | +27.3% | -33.9% | -22.5% |
| 1Y | -9.8% | +31.0% | -40.8% | -27.0% |
| All | +258.4% | +103.5% | +154.9% | +122.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling